← Back to Search

Behavioural Intervention

Endeavor™ Action Video Game Treatment for Multiple Sclerosis (Akili Trial)

N/A
Waitlist Available
Led By Leigh Charvet, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study (day 60)
Awards & highlights

Akili Trial Summary

This trialwill study if an app (Endeavor™) can help treat cognitive impairment in kids with MS. Participants will have assessments, use the app at home, then finish with another assessment.

Eligible Conditions
  • Multiple Sclerosis

Akili Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study (day 60)
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study (day 60) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent compliance for total at-home sessions
Secondary outcome measures
Change in Depression in Participants
Change in Fatigue in Adult participants
Change in Fatigue in Pediatric participants
+2 more

Akili Trial Design

1Treatment groups
Experimental Treatment
Group I: Endeavor™ Action Video Game TreatmentExperimental Treatment1 Intervention
25 participants will fill out questionnaires and complete a neuropsychological evaluation. During study participation, participants will target using Endeavor™ action video game to complete 25-30 minutes at-home sessions 5 days a week for a total of 8 weeks via an iOS application.

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,721 Total Patients Enrolled
23 Trials studying Multiple Sclerosis
2,324 Patients Enrolled for Multiple Sclerosis
Leigh Charvet, PhDPrincipal InvestigatorNYU Langone Health
4 Previous Clinical Trials
92 Total Patients Enrolled
3 Trials studying Multiple Sclerosis
82 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible for me to join this medical experimentation?

"To join this clinical trial, applicants must have multiple sclerosis and be between 12 and 22 years old. Currently, it is looking to recruit 25 participants in total."

Answered by AI

Are there any opportunities to enroll in this research initiative currently?

"The data available on clinicaltrials.gov indicates that this trial is not currently looking for participants, having been first posted January 1st 2023 and most recently updated October 17th 2022. Nevertheless, there are presently 549 other trials recruiting patients across the world."

Answered by AI

Does this trial have any age restrictions on those who can participate?

"This clinical trial mandates that all participants are aged between 12 and 22 years old."

Answered by AI

Who else is applying?

What state do they live in?
New York
What site did they apply to?
NYU Langone Health - Ambulatory Care Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
2

Why did patients apply to this trial?

I want to be a part of a change or cure. By volunteering, I can get the best treatment.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Endeavor™ in Pediatric MS
2023. "Endeavor™ in Pediatric MS". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04445116.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top